Status | Study |
NOT_YET_RECRUITING |
Study Name: Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma Condition: Mesothelioma Date: 2023-06-27 Interventions: Durvalumab concentrate for solution for infusion will be supplied in glass vials containing 500 mg durvalumab at a concentration of 50 mg/mL. |
RECRUITING |
Study Name: MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI Condition: Mesothelioma Date: 2023-02-07 Interventions: Intravenous infusion of magnesium sulfate prior to intraoperative chemotherapy with cisplatin. |
Recruiting |
Study Name: A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma Condition: Mesothelioma Date: 2017-03-02 Interventions: Drug: Tremelimumab Tremelimuma |
Completed |
Study Name: Genomic Analysis of Peritoneal Mesothelioma by CGH Arrays Condition: Peritoneal Mesothelioma Date: 2016-04-27 Interventions: Genetic: comparative genomic analysis DNA and RNA extraction will be performed in Lyon University hospit |
Active, not recruiting |
Study Name: Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) Patients Condition: Mesothelioma Date: 2016-03-09 Interventions: Drug: Nivolumab Nivolumab admi |
Recruiting |
Study Name: A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma Condition: Pleural Mesothelioma Date: 2016-02-29 Interventions: Drug: Pembrolizumab Neoadjuvan |
Recruiting |
Study Name: Vinorelbine in Mesothelioma Condition: Mesothelioma Date: 2014-05-09 Interventions: Drug: Vinorelbine Vinorelbine |
Completed |
Study Name: Serum Biomarkers in Diagnosis of Mesothelioma Condition: Mesothelioma Date: 2014-01-06 Interventions: Biological: Mesothelin, hyaluronan, osteopontin, syndecan-1 We compere the serum levels of the tumor mar |
Recruiting |
Study Name: Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma Condition: Mesothelioma Date: 2013-09-21 |
Recruiting |
Study Name: PIT: Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma Condition: Mesothelioma Date: 2012-05-21 Interventions: Radiation: Prophylactic Irradiation of Tracts (PIT) 21 Gy in 3 fractions |